Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

NCT07572396 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

High-risk HPV (Any Strain)
LSIL, Low Grade Squamous Intraepithelial Lesion
ASC-US
HPV Infection
Cervical Abnormalities
Uterine Cervical Dysplasia

Interventions

DRUG: EGCG and Quinine Sulfate Vaginal Suppository
OTHER: Placebo

Sponsor

Amplexd Therapeutics, Inc.

Collaborators

[object Object]
[object Object]